14967170|t|Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
14967170|a|BACKGROUND: Down syndrome (DS) is a chromosomal abnormality (trisomy 21) leading to mental retardation, to the characteristic change of individual's phenotype and to the pathological features of Alzheimer disease. Patients with DS have elevated ratio of superoxide dismutase to (catalase plus glutathione peroxidase) with respect to controls in all age categories suggesting that oxidative imbalance contributes to the clinical manifestation of accelerated aging. RESULTS: We report that persons with DS have elevated uric acid levels compared with controls, 348.56+/-22.78 versus 284.00+/-20.86 micromol/l (p=0.018). The levels of hypoxanthine and xanthine in DS children (6.35+/-0.31 and 1.02+/-0.23 micromol/l) were significantly lower than in controls (7.83+/-0.59 and 2.43+/-0.66 micromol/l). This result suggests increased conversion of hypoxanthine and xanthine to uric acid with subsequent free radical-dependent oxidation of uric acid to allantoin, mechanisms potentiated by the oxidative stress in DS. Allantoin is a nonenzymatic oxidative product of uric acid in human. In DS individuals, the levels of allantoin were significantly higher than those in healthy controls (18.58+/-2.27 and 14.07+/-1.07 micromol/l, respectively, p=0.03). CONCLUSIONS: Our data supported the presumption of increased oxidative stress in DS.
14967170	0	9	Uric acid	Chemical	MESH:D014527
14967170	14	23	allantoin	Chemical	MESH:D000481
14967170	34	47	Down syndrome	Disease	MESH:D004314
14967170	106	119	Down syndrome	Disease	MESH:D004314
14967170	121	123	DS	Disease	MESH:D004314
14967170	130	153	chromosomal abnormality	Disease	MESH:D002869
14967170	155	165	trisomy 21	Disease	MESH:D004314
14967170	178	196	mental retardation	Disease	MESH:D008607
14967170	289	306	Alzheimer disease	Disease	MESH:D000544
14967170	308	316	Patients	Species	9606
14967170	322	324	DS	Disease	MESH:D004314
14967170	373	381	catalase	Gene	847
14967170	595	597	DS	Disease	MESH:D004314
14967170	612	621	uric acid	Chemical	MESH:D014527
14967170	726	738	hypoxanthine	Chemical	MESH:D019271
14967170	743	751	xanthine	Chemical	MESH:D019820
14967170	755	757	DS	Disease	MESH:D004314
14967170	937	949	hypoxanthine	Chemical	MESH:D019271
14967170	954	962	xanthine	Chemical	MESH:D019820
14967170	966	975	uric acid	Chemical	MESH:D014527
14967170	1028	1037	uric acid	Chemical	MESH:D014527
14967170	1041	1050	allantoin	Chemical	MESH:D000481
14967170	1102	1104	DS	Disease	MESH:D004314
14967170	1106	1115	Allantoin	Chemical	MESH:D000481
14967170	1155	1164	uric acid	Chemical	MESH:D014527
14967170	1168	1173	human	Species	9606
14967170	1178	1180	DS	Disease	MESH:D004314
14967170	1208	1217	allantoin	Chemical	MESH:D000481
14967170	1422	1424	DS	Disease	MESH:D004314
14967170	Association	MESH:D004314	847
14967170	Association	MESH:D000481	MESH:D004314
14967170	Association	MESH:D014527	MESH:D019820
14967170	Positive_Correlation	MESH:D014527	MESH:D004314
14967170	Association	MESH:D019820	MESH:D004314
14967170	Comparison	MESH:D000481	MESH:D014527
14967170	Association	MESH:D019271	MESH:D004314
14967170	Association	MESH:D014527	MESH:D019271
14967170	Positive_Correlation	MESH:D000481	MESH:D019820

